Comparison of ketorolac-induced analgesia with ketamine in lumbar fusion surgery patients using PCA pain pump

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160403027191N5

Enrollment

120

Registered

2023-10-29

Start date

2023-11-01

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar fusion. Fusion of spine, lumbar region

Interventions

Intervention 1: Intervention group 1: Ketamine vial: Ketamine used in this study in group A, each milliliter of which contains 50 mg of ketamine (500mg/10ml) and is produced by STEROP-Belgium in Germa

Eligibility

Sex/Gender

All

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: The patient's willingness to participate in the study and obtain informed consent Performing lumbar fusion surgery during the research Being 20 to 75 years old

Exclusion criteria

Exclusion criteria: History of previous spine surgery Known hypersensitivity to ketamine or ketorolac Occurrence of any unusual complications during surgery Substance abuse and psychoactive drugs

Design outcomes

Primary

Measure	Time frame
Intensity of pain. Timepoint: at 2, 4, 6, 12, 18, 24 hours after surgery. Method of measurement: check list.	—

Secondary

Measure	Time frame
Time of return from Ileus. Timepoint: At times 2, 4, 6, 12, 18, 24 hours after surgery. Method of measurement: check list.;Nausea and vomiting. Timepoint: At times 2, 4, 6, 12, 18, 24 hours after surgery. Method of measurement: check list.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbdolmajid Gholi Nataj Jelodar

Mazandaran University of Medical Sciences

gholinataj54@mazums.ac.ir+98 11 3325 5348

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026